EPAT | Shockwave Therapy


EPAT (Shockwave Therapy) is a highly effective treatment method: deep penetrating sound waves are targeted at the source of injury to kickstart the healing process so that the body can regenerate tissue. It is one of the most advanced and highly effective noninvasive treatment methods cleared by the FDA.

The treatment works by helping to improve the regenerative potential, and enhancing blood circulation to regenerate damaged tissue.

It works by introducing high acoustic sound waves into the body, penetrating tissue, stimulating cells responsible for bone and connective tissue healing.  EPAT uses your existing and natural healing agents such as red blood cells, growth factors and mobilizes stem cells.

Research has shown the following benefits:

  • Planter Fasciitis
  • Achilles
  • Stress Fractures
  • Knee Pain
  • Heel Pain
  • Foot Pain
  • Ankle Pain
  • Tendon Pain

  • Hamstring Pain
  • Scar Tissue
  • Back Pain
  • Neck Pain
  • Shoulder Pain
  • Elbow Pain
  • Wrist Pain
  • Hand Pain

Would you like to give it a try?

Schedule a session

How is it used?


The number of sessions needed depends on the condition that is being treated. Each treatment session takes between 10 to 15 minutes and can vary depending on the condition that is being treated and the size of the painful area.

Beneficial effects are often experienced after only 1 or 2 treatments. Many clients report immediate pain relief after treatment, and report being pain free and/or having a significant reduction in pain after only a few sessions. This therapy not only eliminates pain but also restores mobility, thus improving quality of life and athletic performance.  

We offer EPAT as part of our physical therapy treatment.  We take a full body approach, to understand the root cause of injury/pain and if you would benefit from EPAT treatment.  Ask your PT about it at your next PT visit.


Would you like to give it a try?

Schedule a session

Thank you! Your subscription has been confirmed. You'll hear from us soon.
Subscribe to our newsletter: